Skip to content
healthcare.dev
Get a free key

TRYNGOLZA

NDC 71860-101, olezarsen sodium, injection, solution, from Ionis Pharmaceuticals, Inc..

Product NDC
71860-101
Status
Listed
Labeler
Ionis Pharmaceuticals, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA218614
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71860-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLEZARSEN SODIUM80 mg/.8mL

Pharmacologic classes

APOC-III-directed RNA Interaction [EPC]; Antisense Oligonucleotide [EPC]; Antisense [CS]; Increased RNA Degradation [PE]

Package NDCNDC-11Package
71860-101-01718600101011 SYRINGE, GLASS in 1 CARTON (71860-101-01) / .8 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0f51aa8e-8475-8cf9-e063-6394a90a6848

Use it

Look up 71860-101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71860-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71860-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.